Performance for the week
LUPIN cmp 962.40 buy upto 932.00 stop 919.00 target 1005+
Entry 958.50 to 1129.00
*Profit ₹ 1,44,925.00*
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
LUPIN
1,085.7
+48.6 (4.69%)
Updated 03:29 18/09 IST
LUPIN Buy or Sell - FrontPage Forums
3 Users have submitted 3 trade ideas of Rs. 153,335 for LUPIN
Disclaimer100% Bullish
0% Bearish
LUPIN Buy or Sell - Brokerage Reports
No. of reports in last year
7
No. of analysts
3
Average Consensus Forecast
829.57
Consensus Potential
-27.60%
LUPIN Ratings
Long term LUPIN rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
3.3/5 (8 Ratings)
Find answers to all your questions on live LUPIN message board: Is LUPIN buy or sell? Should I buy LUPIN shares? Why are LUPIN shares falling? Should I invest in LUPIN stock?
- Home
- LUPIN Forum
LUPIN Share Price Discussion
S
Reputation: -10,439 • Yesterday 11:52 AM
simran in MCX-NATURALGASNew trade: Buy NATURALGAS 25SEP20 FUT, CMP@146....
149 #NATURALGAS
Like
Reply
S
Reputation: 51,959 • Yesterday 11:52 AM
Performance for the week
CADILLAHC cmp 372.35 buy upto 361.00 stop 356.70 target 396.00/411.00+
Entry 366.50 to 424.25
*Profit ₹ 1,27,050.00*
Like
Reply
S
Reputation: -10,439 • Yesterday 11:52 AM
simran in MCX-NATURALGASNew trade: Buy NATURALGAS 25SEP20 FUT, CMP@146....
148.90 #NATURALGAS
Like
Reply
S
Reputation: 164 • Yesterday 11:51 AM
#GOLD buy bid gold 51400 sl 51340 tgt 51800/950/52200 interday
Like
Reply
N
Reputation: 6,008 • Yesterday 11:41 AM
CAG raps PGCIL for shoddy infra planning; non-collection of Rs 6853 cr charges
In its audit findings CAG said that no network plan was found available in the records or on the website of the central transmission utlitiy, Power Grid Corp.
In its audit findings CAG said that no network plan was found available in the records or on the website of the central transmission utlitiy, Power Grid Corp.
The Economic Times
Like
Reply
N
Reputation: 6,008 • Yesterday 11:41 AM
Market Movers: Pharma stocks on a high, Happiest slips; 139 stocks flash buy signals
Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said Nifty may trade rangebound with a negative bias in the short term
Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said Nifty may trade rangebound with a negative bias in the short term
The Economic Times
Like
Reply
N
Reputation: 6,008 • Yesterday 11:41 AM
HDFC, India's largest private lender, worth erodes 11% to $20.26 billion
LIC and TCS were ranked second and third, retaining their positions from last year even as both declined 9% and 20% each. In fact, this years ranking worth $216 bn in brand value fell 6% over last year, largely due to slowdown in the banking and automotive sectors. Indias top brands, however, performed well against other countries where declines in brand value were far greater.
LIC and TCS were ranked second and third, retaining their positions from last year even as both declined 9% and 20% each. In fact, this years ranking worth $216 bn in brand value fell 6% over last year, largely due to slowdown in the banking and automotive sectors. Indias top brands, however, performed well against other countries where declines in brand value were far greater.
The Economic Times
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
LUPIN Share Price - Technicals
- NewsBotYesterday 5:46 AM
Stock market news: Lupin shares leaps 7%The Economic TimesNewsBotAug 27 7:48 AM
Buy Lupin; target of Rs 1130: Motilal OswalMoneycontrolNewsBotAug 27 7:43 AM
Buy Lupin; target of Rs 1085: Prabhudas LilladherMoneycontrolNewsBotAug 26 8:01 AM
New asthma drug to lift earnings for Lupin, but will it be enough to make shareholders happy?The Economic TimesNewsBotAug 26 4:21 AM
Buy Lupin, target price Rs 1130: Motilal OswalThe Economic TimesNewsBotAug 25 4:33 AM
Lupin gets USFDA nod for asthmatic symptoms prevention drugMoneycontrolNewsBotAug 25 4:16 AM
Lupin gets US health regulator's approval for asthmatic symptoms prevention drugThe Economic TimesNewsBotAug 25 3:38 AM
Lupin share price rises 5% on US FDA approvalMoneycontrolNewsBotAug 24 6:58 AM
Lupin shars slips 2% after Investec retains 'sell' but raises targetMoneycontrolNewsBotAug 16 1:33 AM
Buy Trent; target of Rs 680: ICICI DirectMoneycontrol
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.